ONCOMARK
OncoMark is a UCD spin-out that develops companion diagnostic tests to support cancer drug development. Companion diagnostics allow pharmaceutical companies to select patients for which a drug may be particularly effective (patient stratification). The test can also be used during clinical trials to help reduce the numbers of patients required to complete a clinical trial and its duration, while also increasing the likelihood that the trial will be successful. The end result is improved outcome... for cancer patients. The company has a portfolio of diagnostic tests in development, covering some of the key cancer types (breast, colorectal, prostate, melanoma), supported by €3.9m in EU R&D funding. There are currently 12 employees funded through 6 grants. The company was founded by Prof. William Gallagher in UCD and is led by Dr. Mairin Rafferty, the CEO/COO. The company has a strong advisory board, which includes Prof. John Crown and Prof. Bryan Hennessy.
ONCOMARK
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2007-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.oncomark.com
Total Employee:
11+
Status:
Active
Contact:
353 1 716 3666
Email Addresses:
[email protected]
Total Funding:
5.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apache Google Apps For Business Mobile Optimized FLoC Opt-Out FLoC Drupal
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
Investors List
Enterprise Ireland
Enterprise Ireland investment in Venture Round - Oncomark
Enterprise Ireland
Enterprise Ireland investment in Venture Round - Oncomark
Kernel Capital
Kernel Capital investment in Venture Round - Oncomark
Irrus Investments
Irrus Investments investment in Venture Round - Oncomark
Bank of Ireland
Bank of Ireland investment in Venture Round - Oncomark
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Oncomark
Official Site Inspections
http://www.oncomark.com
- Host name: 104.21.48.1
- IP address: 104.21.48.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Oncomark"
Oncomark - Crunchbase Company Profile & Funding
OncoMark is a UCD spin-out that develops companion diagnostic tests to support cancer drug …See details»
OncoMark Company Profile 2024: Valuation, Investors ... - PitchBook
OncoMark General Information Description. Developer of a healthcare device intended to cut …See details»
Oncomark - LinkedIn
OncoMark Ltd. is a private company centred on the development and application of biomarker …See details»
OncoMark - Products, Competitors, Financials, Employees, …
US medtech acquires UCD spin-out OncoMark. Dec 17, 2021. University College Dublin (UCD) …See details»
OncoMark - Overview, News & Competitors | ZoomInfo.com
OncoMark. Business Services · Ireland · <25 Employees. OncoMark is a diagnostics company …See details»
Oncomark - Funding, Financials, Valuation & Investors - Crunchbase
OncoMark is an Irish diagnostics company dedicated to develop superior tests for cancer …See details»
OncoMark - Royal College of Surgeons in Ireland
“OncoMark’s novel breast cancer prognostic test is a powerful tool in identifying patients with …See details»
Oncomark Company Profile - Office Locations, Competitors ... - Craft
OncoMark Ltd. is a private company centred on the development and application of biomarker …See details»
Cepheid acquires Oncomark - 2021-12-16 - Crunchbase
Dec 16, 2021 Oncomark OncoMark is an Irish diagnostics company dedicated to develop …See details»
UCD Spin-out OncoMark acquired by US molecular diagnostic firm
Dec 17, 2021 With the acquisition of OncoMark by Cepheid, it will now be launched on …See details»
UCD Spin-out acquired by US molecular diagnostic company
Des O’Leary, former OncoMark CEO, and now OncoAssure CEO said: “I am very pleased that …See details»
OncoMark acquired by US molecular diagnostic company, …
Dec 16, 2021 Des O’Leary, former OncoMark CEO, and now OncoAssure CEO, said: “I am …See details»
OncoMark, the UCD-based cancer diagnostics company, raises …
Feb 15, 2017 A new breast cancer diagnostic test is nearing the market after OncoMark, a …See details»
OncoMark Acquired by Cepheid - University College Dublin
Dec 16, 2021 Des O’Leary, former OncoMark CEO, and now OncoAssure CEO said, “I am …See details»
Oncomark - Contacts, Employees, Board Members, Advisors
Organization. Oncomark . Connect to CRM . Save . Summary. Financials. People. Technology. …See details»
US medtech acquires UCD spin-out OncoMark
Dec 16, 2021 OncoMark was founded by Prof William Gallagher and Steve Penney as a spin …See details»
Our Technology – OncoMark
OncoMark: A highly innovative, non-invasive biomarker test for early lung cancer detection and …See details»
OncoMark: avoiding unnecessary chemotherapy in breast cancer …
Jan 24, 2024 “OncoMark is an excellent example of the quality of the spin-outs which have …See details»
Oncomark medical device development – a pipeline landscape
Oncomark and its subsidiaries are currently working on the development of 8 products that fall …See details»
UCD spin-out acquired by US molecular diagnostics company
Des O’Leary, former OncoMark CEO, and now OncoAssure CEO said, “I am very pleased that …See details»